Market News

Moderna shares fall after company cuts 2021 forecast for Covid vaccine sales

0

Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021.

Boston Globe | Getty Images

Moderna shares fell 8% on Thursday after it cut its Covid-19 vaccine sales forecast for the year to between $15 billion and $18 billion from $20 billion.

This is a developing story. Please check back for updates.

Tough times for income investors: Even with payouts at a record, dividend yields are measly

Previous article

Ford to repurchase up to $5 billion in junk bonds as it restructures its balance sheet

Next article

You may also like

Comments

Leave a reply

Your email address will not be published.

More in Market News